Currus Biologics

Melbourne, Australia

Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.

May 2024

Venture - Series Unknown

Biotechnology Therapeutics

Top Investors

Brandon Capital Uniseed Brandon BioCatalyst Medical Research Commercialisation Fund (MRCF)

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Currus Biologics

Who are Currus Biologics's investors?

Currus Biologics's investors include Brandon Capital, Uniseed, Brandon BioCatalyst, Medical Research Commercialisation Fund (MRCF).

Where is Currus Biologics headquartered?

Currus Biologics is headquartered in Melbourne, Australia.

What does Currus Biologics do?

Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.

What stage is Currus Biologics at?

Currus Biologics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 7, 2024.

MLA

"Currus Biologics — Funding & Investors." VCBacked, May 7, 2024, https://www.vcbacked.co/company/currus-biologics. Accessed July 3, 2026.

APA

VCBacked. (2024). Currus Biologics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/currus-biologics

Wikipedia (cite web)

{{cite web |title=Currus Biologics — Funding & Investors |url=https://www.vcbacked.co/company/currus-biologics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 7, 2024.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K